These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 14038707)

  • 21. [Aldactone (aldosterone antagonist SC-9, 420) in the treatment of the edemas of heart patients and cirrhotic patients. Bioclinical study].
    PAGET M; LANGERON L; CROCCEL L; ROUTIER G; CROCCEL E; PROTIN M
    J Sci Med Lille; 1962 May; 80():225-35. PubMed ID: 14483183
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of the ascites and edema of cirrhotics by spironolactone].
    MINICONI P; BOURREILLE J; SUDUCA P; CARAYON P; LAVOCAT G; ISSAD H
    Alger Medicale; 1962 Jan; 66():1-98. PubMed ID: 14474319
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of ascites, non respondive to drug therapy, with an artificial kidney].
    Shvok EA; Dutts V; Tsiprikh B; Shmidt V; Nilius R
    Ter Arkh; 1983; 55(2):107-9. PubMed ID: 6845186
    [No Abstract]   [Full Text] [Related]  

  • 24. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diuretic treatment of hepatic cirrhosis: use of distal diuretics].
    Escartin Marín P; Arenas Mirave I; Alvarez Bustos G; Arenas de Pablo A; García Plaza A
    Rev Clin Esp; 1974 Jan; 132(1):65-70. PubMed ID: 4840230
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined diuretic and steroid therapy in cirrhosis with ascites.
    MORRISON RS; CHALMERS TC
    Ann N Y Acad Sci; 1960 Oct; 88():907-14. PubMed ID: 13772890
    [No Abstract]   [Full Text] [Related]  

  • 27. [Management of ascitis in patients with cirrhosis].
    Arfaoui D; Ajmi S
    Tunis Med; 2007 Feb; 85(2):91-5. PubMed ID: 17665651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cirrhotic edemas and spironolactone].
    ALBAHARY C; POMMEY B
    Concours Med; 1962 Mar; 84():1759-66. PubMed ID: 13860028
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Contribution to the study of the treatment of the ascitic syndrome of cirrhosis by the combination of spironolactone and sulfonamide diuretic. Initial therapy and supportive therapy. Apropos of 55 cases].
    Fraisse H; Perret M; Etaix JP
    J Med Lyon; 1967 Feb; 48(114):173-83. PubMed ID: 5600100
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ascites in patients with cirrhosis. Questions for Professor Dominique Valla].
    Valla D
    Gastroenterol Clin Biol; 1999 Mar; 23(3):390-2. PubMed ID: 10384344
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
    Torre A; Terra C; Guevara M; Ginès P
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529
    [No Abstract]   [Full Text] [Related]  

  • 34. Resistant ascites treated by combined diuretic therapy (spironolactone, mannitol, and chlorothiazide).
    SHALDON S; McLAREN JR; SHERLOCK S
    Lancet; 1960 Mar; 1(7125):609-13. PubMed ID: 14445413
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of edema in liver cirrhosis with a spirolactone, aldactone].
    ETIENNE-MARTIN P; KLEPPING C; GUERRIN J; DUSSERRE
    Lyon Med; 1961 May; 93():1095-104. PubMed ID: 13697487
    [No Abstract]   [Full Text] [Related]  

  • 36. [Action of a spirolactone in an edematous syndrome of cirrhotic origin].
    HERBEUVAL R; CUNY G; DUHEILLE J; GUERCI O; PETITIER H
    Rev Med Nancy; 1961; 86():778-84. PubMed ID: 13906642
    [No Abstract]   [Full Text] [Related]  

  • 37. [THE SIGNIFICANCE OF DYSREGULATION CAUSED BY DIURETICS IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS].
    BRUNNER E
    Wien Klin Wochenschr; 1963 Sep; 75():674-7. PubMed ID: 14059193
    [No Abstract]   [Full Text] [Related]  

  • 38. [ON THE DIURETIC EFFECT OF THE ADRENOSTATIC DRUG METHOPYRAPONE].
    HIERHOLZER K
    Dtsch Med Wochenschr; 1964 Jun; 89():1167-73. PubMed ID: 14152375
    [No Abstract]   [Full Text] [Related]  

  • 39. [First results obtained with the use of the spirolactone SC-9420 (aldactone) in the treatment of ascites caused by liver cirrhosis].
    DE FILIPPIS V; MARSICO F; PEDICINI S
    Riforma Med; 1960 Dec; 74():1516-20. PubMed ID: 13720490
    [No Abstract]   [Full Text] [Related]  

  • 40. Medical management of ascites in cirrhosis of the liver. II. Aldosterone antagonists.
    RIVERA A; VELASCO F; SUAREZ MA; DIES F
    Clin Pharmacol Ther; 1963; 4():154-61. PubMed ID: 13974133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.